Home
About Us
Our Mission
Management
Board of Directors
Science Advisors
Science & Pipeline
Overview
Neuroplasticity
DMX-1001
Alcohol use disorder
Publications
Investors & Media
Media releases
News beats
For Investors
Media contact
Contact DemeRx
DemeRx Taps Michael Snitkovsky as New COO
changes
News beats
10 Jul at 3:03 pm
Read Article
Next Post
DemeRx Appoints Michael Snitkovsky as Chief Operating Officer to Advance Clinical Pipeline
Previous Post
DemeRx Announces FDA Acceptance of IND Application to Advance DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)
Menu
